HIV can establish itself in the brain as soon as four months after initial infection.
A team of researchers has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease.
Scientists call for a global strategy for the development of new tuberculosis vaccines.
Study finds vaccination rate far below what's needed to keep virus in check.
Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton.
The project will focus on finding cures for aging-related diseases like cataracts and atherosclerosis.
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by University of Otago cancer genetics researchers.
Apple's ResearchKit needs to make an impact beyond the initial launch period.
Many recent meta-studies find hormone replacement therapy lengthens life after all. This may be leading to a comeback for the once hugely popular menopause treatment.
Can a tetanus shot help treat brain cancer? A small study hints that it might.
Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.
Basal cell carcinomas develop mutations in a protein on the Hedgehog pathway to evade a common drug therapy. Targeting another portion of the pathway may be an effective alternative treatment.
Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation's largest pharmacy benefits manager.
Apple teamed up with a handful of universities to create these medical research applications.
One of every eight patients might benefit from highly successful lymphoma drugs.
Getting a new drug to market is difficult, but the U.S. Food and Drug Administration (FDA) offers a number of ways to help the process along for promising drugs that have potential against serious diseases. One of these options is designation as a breakthrough therapy. This year a number of these therapies are targeted at fighting cancer.
Apple showcased new health programs called Research Kit during a press conference today.
Study in mice identifies mechanism that lowers levels of dopamine and heightens behavior suggesting anxiety and depression.
Future treatments could bind to vulnerable site in viruses causing a variety of diseases.
Researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
Unexpected findings have implications for anti-obesity therapies.
New technologies will help the field of telemedicine drastically grow this year.
Researchers have identified a previously unknown effect of vitamin A in human embryonic development.
23andMe, Inc., the leading personal genetics company, today announced that it has been granted authority by the U.S. Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test under a regulatory classification for novel devices.